Title: REVIEW OF CDC POLICIES FOR IMMUNIZATION OF PERSONNEL WORKING WITH OR POTENTIALLY EXPOSED TO<i>VACCINIA</i>VIRUS
Abstract:Vaccinia vaccine, formerly known as smallpox vaccine, is extremely effective in generating immunity to smallpox (variola), and other closely related viruses of the Orthopox genus, such as monkeypox an...Vaccinia vaccine, formerly known as smallpox vaccine, is extremely effective in generating immunity to smallpox (variola), and other closely related viruses of the Orthopox genus, such as monkeypox and cowpox. Vaccinia was employed to extirpate smallpox by intensive worldwide immunization. Currently, risk of infection with an orthopoxvirus is significant in laboratories only.The primary purpose of this project was to evaluate the risk of infection for those working with and/or around experiments involving variola and nonvariola Orthopox viruses. The recommendations for the use of vaccinia vaccine were reviewed and clarified. Another objective was to consider the use of smallpox virus as a biological warfare agent. A review of the published guidelines for vaccinia vaccine was conducted. Interviews with experts at the CDC and a tour of the Lawrenceville animal facility served to update risk assessments.Read More
Publication Year: 2001
Publication Date: 2001-01-01
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot